kabutan

Genky DrugStares, Jul-Mar (Cumulative 3Q) Ordinary Profit Increases by 16%

Tue Apr 28, 2026 3:30 pm JST Earnings

9267 Genky DrugStores Co.,Ltd. 【J-GAAP】

Earnings Report

Genky DrugStores Co.,Ltd. <9267> [TSE Prime] announced its financial results after the market closed on April 28th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending June 2026 (July 2025 to March 2026) increased 15.9% from the same period last year, reaching 8.16 billion yen. However, Progress toward the full-year plan of 11.2 billion yen was 72.9%, almost the same as the five-year average of 72.4%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the April to June period (4Q) is expected to grow 6.3% from the same period last year, reaching 3.03 billion yen.

In the most recent three-month period, from January to March (3Q), the consolidated ordinary profit amounted to 2.32 billion yen, an increase of 0.04% compared to the same period last year. However, the operating profit margin remained almost flat, changing from 4.6% in the same period last year to 4.4%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jul - Mar, 2023 136,587 6,494 6,688 4,456 146.7 72.2 Apr 25, 2024 J-GAAP
Jul - Mar, 2024 147,383 6,839 7,046 4,873 160.3 71.2 Apr 28, 2025 J-GAAP
Jul - Mar, 2025 161,710 8,022 8,168 5,621 184.6 72.9 Apr 28, 2026 J-GAAP
YoY +9.7% +17.3% +15.9% +15.3% +15.1%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2025 102,028 5,062 5,177 3,798 125.0 6.50 Jul 29, 2025 J-GAAP
Jan - Jun, 2026 Guidance 111,939 5,333 5,357 3,830 125.6 6.50 Jan 22, 2026 J-GAAP
YoY +9.7% +5.4% +3.5% +0.8% +0.5%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jun, 2024 184,860 9,015 9,268 6,324 208.2 12.75 Jul 29, 2024 J-GAAP
Jun, 2025 200,786 9,658 9,899 7,066 232.5 13 Jul 29, 2025 J-GAAP
Jun, 2026 Guidance 221,200 11,050 11,200 7,850 257.4 13 Jan 22, 2026 J-GAAP
YoY +10.2% +14.4% +13.1% +11.1% +10.7%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2025 48,625 2,243 2,324 1,605 52.8 4.6 Apr 28, 2025 J-GAAP
Apr - Jun, 2025 53,403 2,819 2,853 2,193 72.2 5.3 Jul 29, 2025 J-GAAP
Jul - Sep, 2025 56,042 2,916 2,959 2,037 67.0 5.2 Oct 29, 2025 J-GAAP
Oct - Dec, 2025 53,219 2,801 2,884 1,983 65.2 5.3 Jan 27, 2026 J-GAAP
Jan - Mar, 2026 52,449 2,305 2,325 1,601 52.6 4.4 Apr 28, 2026 J-GAAP
YoY +7.9% +2.8% +0.0% -0.2% -0.4%

Related Articles